Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gregson

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Cancers|July 9, 2022
Survival Outcomes and Prognostic Factors in GlioblastomaNicholas F Brown, Diego Ottaviani, John Tazare, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2024
Quantifying the benefit-risk trade-off for individual patients in a clinical trial: principles and antithrombotic case studyStuart J Pocock, Ruth Owen, John Gregson, et al.
Annals of Intensive Care|August 6, 2021
Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort studyNuttha Lumlertgul, Leah Pirondini, Enya Cooney, et al.
Journal of the American College of Cardiology|September 4, 2024
Competing Risks in Clinical Trials: Do They Matter and How Should We Account for Them?John Gregson, Stuart J Pocock, Stefan D Anker, et al.
Journal of the American College of Cardiology|May 20, 2017
Reply: Last Nail in the Coffin for Propensity Scores in Observational Cardiovascular Studies?Markus C Elze, John Gregson, Usman Baber, et al.
Journal of Cardiovascular Translational Research|January 9, 2021
Number of Antithrombotic Drugs Used Early and In-hospital Outcomes in Acute Coronary SyndromesRoberto Martín-Asenjo, John Gregson, Xavier Rossello, et al.
Plos One|July 14, 2015
Serum Alkaline Phosphatase and Risk of Incident Cardiovascular Disease: Interrelationship with High Sensitivity C-Reactive ProteinSetor K Kunutsor, Stephan J L Bakker, Jenny E Kootstra-Ros, et al.
Journal of the American College of Cardiology|September 27, 2023
Recurrent Events in Cardiovascular Trials: JACC State-of-the-Art ReviewJohn Gregson, Gregg W Stone, Deepak L Bhatt, et al.
The Lancet. Diabetes & Endocrinology|April 14, 2015
BMI and risk of dementia in two million people over two decades: a retrospective cohort studyNawab Qizilbash, John Gregson, Michelle E Johnson, et al.
Revista Espanola De Cardiologia (English Ed.)|March 15, 2017
Association Between Clinical Pathways Leading to Medical Management and Prognosis in Patients With NSTEACSHéctor Bueno, Stuart Pocock, Jesús Medina, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Cancers|July 9, 2022
Survival Outcomes and Prognostic Factors in GlioblastomaNicholas F Brown, Diego Ottaviani, John Tazare, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2024
Quantifying the benefit-risk trade-off for individual patients in a clinical trial: principles and antithrombotic case studyStuart J Pocock, Ruth Owen, John Gregson, et al.
Annals of Intensive Care|August 6, 2021
Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort studyNuttha Lumlertgul, Leah Pirondini, Enya Cooney, et al.
Journal of the American College of Cardiology|September 4, 2024
Competing Risks in Clinical Trials: Do They Matter and How Should We Account for Them?John Gregson, Stuart J Pocock, Stefan D Anker, et al.
Journal of the American College of Cardiology|May 20, 2017
Reply: Last Nail in the Coffin for Propensity Scores in Observational Cardiovascular Studies?Markus C Elze, John Gregson, Usman Baber, et al.
Journal of Cardiovascular Translational Research|January 9, 2021
Number of Antithrombotic Drugs Used Early and In-hospital Outcomes in Acute Coronary SyndromesRoberto Martín-Asenjo, John Gregson, Xavier Rossello, et al.
Plos One|July 14, 2015
Serum Alkaline Phosphatase and Risk of Incident Cardiovascular Disease: Interrelationship with High Sensitivity C-Reactive ProteinSetor K Kunutsor, Stephan J L Bakker, Jenny E Kootstra-Ros, et al.
Journal of the American College of Cardiology|September 27, 2023
Recurrent Events in Cardiovascular Trials: JACC State-of-the-Art ReviewJohn Gregson, Gregg W Stone, Deepak L Bhatt, et al.
The Lancet. Diabetes & Endocrinology|April 14, 2015
BMI and risk of dementia in two million people over two decades: a retrospective cohort studyNawab Qizilbash, John Gregson, Michelle E Johnson, et al.
Revista Espanola De Cardiologia (English Ed.)|March 15, 2017
Association Between Clinical Pathways Leading to Medical Management and Prognosis in Patients With NSTEACSHéctor Bueno, Stuart Pocock, Jesús Medina, et al.
Pageof 12